AbbVie Inc. — Director's Dealing 2021

Mar 3, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AbbVie Inc. (ABBV)
CIK: 0001551152
Period of Report: 2021-02-28

Reporting Person: SALEKI-GERHARDT AZITA (EVP, Operations)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-02-28	Common Stock, $0.01 par value	F	15785	$107.74	Disposed	116284	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock, $0.01 par value	2193	Indirect
Common Stock, $0.01 par value	3873	Indirect

Footnotes

F1: Balance in AbbVie Savings program as of November 10, 2020.

F2: The reporting person disclaims beneficial ownership of all securities held by her spouse.